SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $2,703,471,368 |
| Positions | 86 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| CARIS LIFE SCIENCES INC | CAI | COM | $147,122,490 | 8,256,032 |
| HINGE HEALTH INC | HNGE | CL A | $110,400,541 | 1,330,127 |
| GLAUKOS CORP | GKOS | COM | $82,727,718 | 591,927 |
| EDGEWISE THERAPEUTICS INC | EWTX | COM | $81,136,688 | 1,996,965 |
| SPYRE THERAPEUTICS INC | SYRE | COM NEW | $78,079,080 | 879,467 |
| IRHYTHM HOLDINGS INC | IRTC | COM | $77,824,465 | 654,262 |
| NEOGENOMICS INC | NEO | COM NEW | $71,756,567 | 4,918,202 |
| KODIAK SCIENCES INC | KOD | COM | $69,633,909 | 1,787,318 |
| XENON PHARMACEUTICALS INC | XENE | COM | $68,294,443 | 1,131,452 |
| ALPHATEC HLDGS INC | Unresolved | NOTE 0.750% 3/1 | $66,183,358 | 69,121,000 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.